Skip to main content
Ayalew Tefferi, MD, Hematology, Rochester, MN

AyalewTefferiMD

Hematology Rochester, MN

Professor of Hematology & Oncology, Mayo Medical School

Dr. Tefferi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tefferi's full profile

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1986 - 1989
  • Ascension Illinois/Saint Joseph (Chicago)
    Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 1983 - 1986
  • University of Athens
    University of AthensClass of 1981

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1986 - 2025
  • IL State Medical License
    IL State Medical License 1983 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2013-2014
  • America's Top Doctors for Cancer Castle Connolly, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Functional Interrogation of Variants of Undetermined Significance of the Isocitrate Dehydrogenase 1 and 2 Genes in Myeloid Neoplasms
    Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neo...
    Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Clinical Categorization of Chronic Myelomonocytic Leukemia into Proliferative and Dysplastic Subtypes Correlates with Distinct Genomic, Transcriptomic and Epigenomic S...
    Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Trainee Didactic Sessions: How to Set Up a Clinical Research Program 
    60th American Society of Hematology Annual Meeting - 12/3/2018
  • Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Prospective Evaluation of Vitamin B1 (thiamine) Level in Myeloproliferative Neoplasms: Clinical Correlations and Impact of JAK2 Inhibitor Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Other

Press Mentions

  • Mayo Researchers Develop New Genetics-Based Prognostic Tool for Myelodysplastic Syndrome
    Mayo Researchers Develop New Genetics-Based Prognostic Tool for Myelodysplastic SyndromeOctober 1st, 2018
  • A Milestone Event in Geron’s Imetelstat Phase II Study for Myelofibrosis Patients May Be Imminent
    A Milestone Event in Geron’s Imetelstat Phase II Study for Myelofibrosis Patients May Be ImminentMay 31st, 2016
  • Should the Government Cap the Cost of Cancer Drugs
    Should the Government Cap the Cost of Cancer DrugsJuly 30th, 2015
  • Join now to see all